KCC2 and Spinal Cord Injury
KCC2 和脊髓损伤
基本信息
- 批准号:10599160
- 负责人:
- 金额:$ 42.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-03-15 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:4-AminopyridineAgonistAnatomyAxonBilateralBrainCell membraneChronicContusionsDown-RegulationEsthesiaGrowthHindlimbHumanIGF1 geneImmunohistochemistryIn Situ HybridizationInjuryLesionLightLumbar spinal cord structureMediatingMembraneMessenger RNAModelingMotorMotor CortexMotor NeuronsMovementMusMuscleMuscular AtrophyNeuronsParalysedPathway interactionsPatientsPlayProteinsRattusRecovery of FunctionRehabilitation therapyRoleSpinalSpinal CordSpinal cord damageSpinal cord injuryTestingTimeTrainingVertebral columnclinically relevantdeprivationdesignexcitatory neuronfunctional restorationglial cell-line derived neurotrophic factorinhibitory neuroninsightnerve supplynovelnovel strategiesosteopontinoverexpressionrestorationtransmission process
项目摘要
Abstract/Project Summary
Most human spinal cord injuries (SCIs) are anatomically incomplete, with spared axons spanning the
damaged spinal segments. However, about a half of these patients have a total loss of muscle control and
sensation below the injury level. An important but under-studied question is why such spared connections
fail to mediate functional recovery in these cases. Recent advances in human studies show that epidural
stimulation combined with rehabilitative training allows some chronically paralyzed patients with SCI to
regain voluntary movement, highlights the feasibility of reactivating such dormant spinal circuitry. However,
the limited functional recovery only occurs when the stimulation is on. Thus, understanding why this spared
spinal circuitry is dysfunctional after SCI, and how it can best be reactivated, should provide key insights
into developing novel functional restoration strategies for SCI. In mice with staggered bilateral hemisections,
in which the lumbar spinal cord is deprived of all direct brain-derived innervation but dormant relay circuits
remain between the damaged segments, we discovered that systematic treatment with a KCC2 agonist, or
over-expression of KCC2, is able to restore stepping ability in these paralyzed mice. We showed that such
manipulations are able to correct over-inhibition within the spinal relay zone, allowing this detour circuit to
transmit the brain-derived commands to the hindlimb motor command center in the lumbar spinal cord,
leading to functional recovery. With these exciting preliminary results, this proposed study will address
several related questions: what is the mechanism underlying injury-induced KCC2 down-regulation in
injured spinal cord? Why the achieved functional recovery is partial and how to further enhance such
functional recovery? What are the effects of these circuit-modifying treatments in more clinically relevant
injury models, namely severe contusion models?
摘要/项目摘要
大多数人类脊髓损伤(SCI)在解剖学上是不完整的,宽阔的轴突跨越
脊柱段受损。但是,这些患者中约有一半的肌肉控制总损失
感觉低于伤害水平。一个重要但研究不足的问题是为什么这种不幸的联系
在这些情况下,无法介导功能恢复。人类研究的最新进展表明硬膜外麻醉
刺激与康复训练相结合,使一些长期瘫痪的SCI患者
恢复自愿运动,突出了重新激活这种休眠脊髓回路的可行性。然而,
有限的功能恢复仅在刺激开始时才发生。因此,理解为什么要幸免
SCI后脊柱电路功能失调,以及如何最好地重新激活它,应提供关键的见解
制定新型的SCI功能恢复策略。在交错双侧半剖面的小鼠中,
腰脊髓被剥夺了所有直接脑源性的神经支配,但处于休眠状态
保持在受损的细分市场之间,我们发现使用KCC2激动剂的系统治疗或
KCC2的过表达能够恢复这些瘫痪的小鼠的垫脚能力。我们证明了这样的
操纵能够纠正脊柱继电区内的过度抑制,从而使该绕道电路得以实现
将脑衍生的命令传输到腰椎脊髓的后肢运动指挥中心,
导致功能恢复。通过这些令人兴奋的初步结果,这项拟议的研究将解决
几个相关问题:受伤引起的KCC2下调的机制是什么
受伤的脊髓?为什么实现的功能恢复是部分的,以及如何进一步增强这样
功能恢复?这些电路修改治疗在更临床相关的情况下有什么影响
伤害模型,即严重的挫伤模型?
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ZHIGANG HE其他文献
ZHIGANG HE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ZHIGANG HE', 18)}}的其他基金
Mechanism and Optimization of CBD-mediated analgesic effects
CBD介导的镇痛作用机制及优化
- 批准号:
10288673 - 财政年份:2019
- 资助金额:
$ 42.02万 - 项目类别:
Mechanism and Optimization of CBD-mediated analgesic effects
CBD介导的镇痛作用机制及优化
- 批准号:
10662464 - 财政年份:2019
- 资助金额:
$ 42.02万 - 项目类别:
Mechanism and Optimization of CBD-mediated analgesic effects
CBD介导的镇痛作用机制及优化
- 批准号:
10018669 - 财政年份:2019
- 资助金额:
$ 42.02万 - 项目类别:
Mechanism and Optimization of CBD-mediated analgesic effects
CBD介导的镇痛作用机制及优化
- 批准号:
10227071 - 财政年份:2019
- 资助金额:
$ 42.02万 - 项目类别:
CRSIPR screening for novel regulators of retinal ganglion cell survival and axonal regeneration
CRSIPR 筛选视网膜神经节细胞存活和轴突再生的新型调节因子
- 批准号:
9920148 - 财政年份:2019
- 资助金额:
$ 42.02万 - 项目类别:
Mechanism and optimization of CBD-mediated analgesic effects (Diversity Supplement)
CBD介导的镇痛作用的机制和优化(多样性补充)
- 批准号:
10915759 - 财政年份:2019
- 资助金额:
$ 42.02万 - 项目类别:
Mechanism and optimization of CBD-mediated analgesic effects (Diversity Supplement)
CBD介导的镇痛作用的机制和优化(多样性补充)
- 批准号:
10714331 - 财政年份:2019
- 资助金额:
$ 42.02万 - 项目类别:
CRSIPR screening for novel regulators of retinal ganglion cell survival and axonal regeneration
CRSIPR 筛选视网膜神经节细胞存活和轴突再生的新型调节因子
- 批准号:
10402334 - 财政年份:2019
- 资助金额:
$ 42.02万 - 项目类别:
相似国自然基金
内源激动剂ArA靶向TMEM175蛋白缓解帕金森病症的分子机制研究
- 批准号:32300565
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Adrb2激动剂在改善呼吸机相关性膈肌功能障碍中的作用与机制研究
- 批准号:82372196
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
新型IL2Rβγ激动剂逐级控释联合放疗对抗三阴性乳腺癌的作用及机制研究
- 批准号:82303819
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于OSMAC-GNPS分析策略的蚂蚱内生真菌Aspergillus sp.中新颖泛PPAR激动剂的发现及治疗NASH研究
- 批准号:82304340
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
探究FSP1激动剂在治疗肾缺血再灌注损伤中的分子机理与应用
- 批准号:82304600
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
GPR39 as a Therapeutic Target in Aging-Related Vascular Cognitive Impairment and Dementia
GPR39 作为衰老相关血管认知障碍和痴呆的治疗靶点
- 批准号:
10734713 - 财政年份:2023
- 资助金额:
$ 42.02万 - 项目类别:
Evaluating a novel, orally-active TREM2-targeting drug in AD
评估一种新型口服活性 TREM2 靶向药物治疗 AD 的效果
- 批准号:
10735206 - 财政年份:2023
- 资助金额:
$ 42.02万 - 项目类别:
Circadian control of neuroinflammation after spinal cord injury
脊髓损伤后神经炎症的昼夜节律控制
- 批准号:
10639178 - 财政年份:2023
- 资助金额:
$ 42.02万 - 项目类别:
The Enteric Glia as a Possible Target for Symptom Relief in Endometriosis
肠胶质细胞作为缓解子宫内膜异位症症状的可能目标
- 批准号:
10625609 - 财政年份:2023
- 资助金额:
$ 42.02万 - 项目类别:
The role of PPARγ in astrocyte pathobiology after exposure to repetitive mild traumatic brain injury
PPARγ 在重复性轻度脑外伤后星形胶质细胞病理学中的作用
- 批准号:
10739968 - 财政年份:2023
- 资助金额:
$ 42.02万 - 项目类别: